Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin S. Sr. Boyle Insider Profile
4 Followers
Kevin S. Sr. Boyle, CEO, Director at Alaunos Therapeutics, holds 798.24K shares in Alaunos Therapeutics (Ticker: TCRT).
Kevin S. Sr. Boyle has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kevin S. Sr. Boyle's holdings
Insider Roles
CEO, Director
Roles that Kevin S. Sr. Boyle holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 17, 2021 - Nov 17, 2022
Return:-25.00%
The most profitable trade made by Kevin S. Sr. Boyle
Kevin S. Sr. Boyle's Trading History
List of latest transactions for each holding click on a transaction to see Kevin S. Sr. Boyle's performance on stock
You May Also Like
Kevin S. Sr. Boyle insider profile FAQ
What is the percentage of profitable transactions made by Kevin S. Sr. Boyle?
The percentage of profitable transactions made by Kevin S. Sr. Boyle is ―.
What is the average return per transaction made by Kevin S. Sr. Boyle?
The average return per transaction made by Kevin S. Sr. Boyle is ―.
What stocks does Kevin S. Sr. Boyle hold?
Kevin S. Sr. Boyle holds: TCRT stocks.
What was Kevin S. Sr. Boyle’s latest transaction?
Kevin S. Sr. Boyle latest transaction was an Uninformative Sell of $9.52K.
What was Kevin S. Sr. Boyle's most profitable transaction?
Kevin S. Sr. Boyle’s most profitable transaction was an Informative Buy of TCRT stock on November 17, 2021. The return on the trade was -25.00%.
What is Kevin S. Sr. Boyle's role in Alaunos Therapeutics?
Kevin S. Sr. Boyle's role in Alaunos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.